Estrogen replacement regimen
OwnerRobert Casper, Gideon Kopernik +1inventors
InventorsRobert Casper, Gideon Kopernik, Zeev Shoham
Life of this patent
Estimating the term…
Abstract
The present invention provides an improved method to deliver estrogen to menopausal women comprising administering ultra-low dose estradiol alternating with standard-dose estradiol.
Claims5
An improved pharmaceutical preparation comprising a plurality of doses arranged in alternating standard dose estrogen phases and ultra-low dose estrogen phases, each phase consisting of from about 1 to about 4 consecutive daily unit doses or an equivalent thereof, wherein the daily unit doses of the standard dose estrogen phases contain an amount of from about 0.5 mg to about 1.0 mg of estradiol, and the daily unit doses of the ultra-low dose of estrogen phases contain an amount selected from-about 0.005 mg to about 0.01 mg of estradiol, for administration to a female in need of estrogen replacement therapy.
Dependencies are inferred from the claim text.